| *Sponsored by Nutriband Inc.
(Nasdaq: NTRB) Makes An Approx. 30% Surge Yesterday (Back On Top Today's Watchlist)
July 3rd Greetings, Friend!
Nutriband Inc. (Nasdaq: NTRB) reigns supreme atop watchlist Thursday. Here's why...
This week's huge news (2 separate articles) may have acted as potential catalysts to help NTRB climb approx. 30% from an 8:00AM EST alert evaluation yesterday of roughly $8.40 to a high of $10.97 Wednesday.
See the company news here:
#1. Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
#2. Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index
Also, it's important recognize that NTRB has a low float under 5Mn shares and several technical indicators triggered across the short, medium, and long term.
Read my initial (Nasdaq: NTRB) report below and consider this innovator for your watchlist. -----
In the last 10 days, we've had two separate breakout ideas explode off their charts.
Catch my June 23rd Nasdaq profile?
Opening at $1.935 on 6/23, that Nasdaq profile set the market ablaze over a few day stretch, running to a high of $5.57 by June 25th.
That $3.50+ move resulted in a surge of approximately 187%!
And last week? Opening Friday at $1.37, that Nasdaq biotech popped to a high of $2.43 before the weekend.
Intraday, that's an incredible move of approximately 77%!
Now, here's something sweet. I’ve got a potential breakout idea that you may want to consider for your radar.
Here's what I'm here to report... First off, his is a low float idea with fewer than 5Mn shares in its float. This means volatility potential could be heightened.
Furthermore, in early May, this Nasdaq idea saw an analyst upgrade create a new $15 target.
From its closing valuation Tuesday, that target suggests a potential upside of 85+%.
And just to fan the flames a bit more, this dynamo blazed a jaw-dropping $7.50+ surge in just two days back in January after one of my alerts.
Now, that's not say the same thing will happen again, but it's more than enough reason as to why Nutriband Inc. (Nasdaq: NTRB) is climbing my watchlist this week.
Why? Part of its due to its innovative approach to transdermal drug delivery and its potential to revolutionize patient care, particularly in the field of pain management and abuse prevention.
The company's primary focus is on developing a portfolio of transdermal pharmaceutical products, with its flagship product being an abuse-deterrent fent-a-nyl patch incorporating their proprietary AVERSA™ technology.
This technology is designed to prevent abuse, misuse, diversion, and accidental exposure of drugs with high abuse potential, addressing a critical issue in the opioid crisis.
Learn More About The Company Here: NTRB Presentation. NTRB Website.
Nutriband's potential for growth and market impact is supported by several key potential catalysts:
#1. A Low Float Scenario: With roughly 4.42Mn shares in its float, volatility potential could be heightened at the drop of a hat.
#2. A $15 Analyst Target: Earlier this month, an analyst at Noble Capital Markets shared a new $15 target for NTRB.
From Tuesday's closing valuation, this target projects NTRB to have a 85+% potential upside.
#3. Bullish Technical Indicators: As of close on Tuesday, Barchart was reporting NTRB to have several triggered technical indicators.
In fact, at close this past Friday, NTRB had at least 12 technicals triggered including the website's composite "Trend Seeker" indicator.
#4. Nutriband And Kindeva Complete Commercial Manufacturing Scale-Up For Aversa.
Nutriband, in partnership with Kindeva Drug Delivery, has successfully completed the commercial manufacturing scale-up for its Aversa™ Fent-a-nyl transdermal patch, which incorporates abuse-deterrent technology to reduce opioid misuse.
This milestone enables the companies to proceed with clinical trials, a critical step toward regulatory approval and commercialization. The collaboration aims to address the opioid crisis by providing safer pain management solutions.
#5. Nutriband Announces New United States Patent Issued For Innovative Technology.
Nutriband has announced the issuance of a new U.S. patent for its AVERSA™ abuse-deterrent transdermal technology, which is designed to prevent the misuse of opioid patches by making them less susceptible to abuse.
This patent strengthens Nutriband’s intellectual property portfolio and supports its mission to combat opioid abuse. The patent covers methods and compositions that deter extraction and misuse of transdermal medications. -----
Coverage is officially reinitiated on Nutriband Inc. (Nasdaq: NTRB). When updates are available, I'll be in touch.
All the best, Dane James Editor Market Pulse Today
(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)
*MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.
Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 07/02/2025 and ending on 07/03/2025 to publicly disseminate information about (NTRB:US) via digital communications. Under this agreement, Thousand Sun Media LLC has been paid seven thousand five hundred USD ("Funds"). To date, including under the previously described agreement, Thousand Sun Media LLC has been paid thirty five thousand USD ("Funds"). These Funds were part of the funds that TD Media LLC received from Nutriband Inc., the issuer of (NTRB:US).
Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (NTRB:US).
Please see important disclosure information here: https://marketpulsetoday.com/disclosure/ntrb-kfqwn/#details | 
0 Response to "(Nasdaq: NTRB) Makes An Approx. 30% Surge Yesterday (Back On Top Today's Watchlist)"
Post a Comment